Biodistribution of 18F-FES in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant (G1T48), a Novel Selective ER Degrader.
J Nucl Med
; 63(5): 694-699, 2022 05.
Article
in En
| MEDLINE
| ID: mdl-34446451
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Receptors, Estrogen
Limits:
Female
/
Humans
Language:
En
Journal:
J Nucl Med
Year:
2022
Document type:
Article